190 related articles for article (PubMed ID: 37024740)
21. Efficacy and safety of endoscopic submucosal dissection for gastrointestinal neuroendocrine tumors: a 10-year data analysis of Northern China.
Chen X; Li B; Wang S; Yang B; Zhu L; Ma S; Wu J; He Q; Zhao J; Zheng Z; Li S; Wang T; Liang L
Scand J Gastroenterol; 2019 Mar; 54(3):384-389. PubMed ID: 31037980
[No Abstract] [Full Text] [Related]
22. Optimization of Endoscopic Submucosal Dissection and Endoscopic Mucosal Resection Strategies for Rectal Neuroendocrine Tumors Within 20 mm.
Yu Q; Zhang Y; Su Y; Zhao Q; Xiong K; Zhang L; Fang H
Am Surg; 2024 Jun; 90(6):1176-1186. PubMed ID: 38192125
[TBL] [Abstract][Full Text] [Related]
23. Comparison of endoscopic submucosal dissection and transanal endoscopic microsurgery for T1 rectal neuroendocrine tumors: a propensity score-matched study.
Park SS; Kim BC; Lee DE; Han KS; Kim B; Hong CW; Sohn DK
Gastrointest Endosc; 2021 Aug; 94(2):408-415.e2. PubMed ID: 33600807
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcomes of endoscopic resection for rectal neuroendocrine tumors: Advantages of endoscopic submucosal resection with a ligation device compared to conventional EMR and ESD.
Kamigaichi Y; Yamashita K; Oka S; Tamari H; Shimohara Y; Nishimura T; Inagaki K; Okamoto Y; Tanaka H; Yuge R; Urabe Y; Arihiro K; Tanaka S
DEN Open; 2022 Apr; 2(1):e35. PubMed ID: 35310732
[TBL] [Abstract][Full Text] [Related]
25. Comparison of endoscopic submucosal resection with ligation and endoscopic submucosal dissection for small rectal neuroendocrine tumors: A multicenter retrospective study.
Matsuno K; Miyamoto H; Kitada H; Yoshimatsu S; Tamura F; Sakurai K; Fukubayashi K; Shono T; Setoyama H; Matsuyama T; Suko S; Narita R; Honda M; Tateyama M; Naoe H; Morinaga J; Tanaka Y; Gushima R
DEN Open; 2023 Apr; 3(1):e163. PubMed ID: 36176350
[TBL] [Abstract][Full Text] [Related]
26. Multiple ligation-assisted endoscopic submucosal resection combined with endoscopic ultrasonography: a novel method to treat rectal neuroendocrine tumors.
Xie J; Hong D; Li D; Jiang C; Xu B; Liu M; Wang W
Eur J Gastroenterol Hepatol; 2023 Feb; 35(2):174-180. PubMed ID: 36574308
[TBL] [Abstract][Full Text] [Related]
27. The clinical outcomes and risk factors associated with incomplete endoscopic resection of rectal carcinoid tumor.
Choi CW; Park SB; Kang DH; Kim HW; Kim SJ; Nam HS; Ryu DG
Surg Endosc; 2017 Dec; 31(12):5006-5011. PubMed ID: 28936630
[TBL] [Abstract][Full Text] [Related]
28. Circumferential submucosal incision prior to endoscopic mucosal resection provides comparable clinical outcomes to submucosal dissection for well-differentiated neuroendocrine tumors of the rectum.
Cheung DY; Choi SK; Kim HK; Kim SS; Chae HS; Seo KJ; Cho YS
Surg Endosc; 2015 Jun; 29(6):1500-5. PubMed ID: 25277474
[TBL] [Abstract][Full Text] [Related]
29. Cap-assisted EMR for rectal neuroendocrine tumors: comparisons with conventional EMR and endoscopic submucosal dissection (with videos).
Yang DH; Park Y; Park SH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yang SK
Gastrointest Endosc; 2016 May; 83(5):1015-22; quiz 1023-.e6. PubMed ID: 26460225
[TBL] [Abstract][Full Text] [Related]
30. Comparison of underwater endoscopic mucosal resection and endoscopic submucosal dissection of rectal neuroendocrine tumors (with videos).
Park SS; Han KS; Kim B; Chang Kim B; Hong CW; Sohn DK; Chang HJ
Gastrointest Endosc; 2020 May; 91(5):1164-1171.e2. PubMed ID: 31904380
[TBL] [Abstract][Full Text] [Related]
31. Risk of lymph node metastasis after endoscopic treatment for rectal NETs 10 mm or less.
Inada Y; Yoshida N; Fukumoto K; Hirose R; Inoue K; Dohi O; Murakami T; Ogiso K; Tomie A; Kugai M; Yoriki H; Inagaki Y; Hasegawa D; Okuda K; Okuda T; Morinaga Y; Kishimoto M; Itoh Y
Int J Colorectal Dis; 2021 Mar; 36(3):559-567. PubMed ID: 33388960
[TBL] [Abstract][Full Text] [Related]
32. Long-term clinical outcomes of endoscopic submucosal dissection in rectal neuroendocrine tumors based on resection margin status: a real-world study.
Sun D; Ren Z; Xu E; Cai S; Qi Z; Chen Z; Liu J; Shi Q; Zhou P; Zhong Y
Surg Endosc; 2023 Apr; 37(4):2644-2652. PubMed ID: 36380122
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of modified endoscopic mucosal resection for rectal neuroendocrine tumors: a meta-analysis.
Zheng JC; Zheng K; Zhao S; Wang ZN; Xu HM; Jiang CG
Z Gastroenterol; 2020 Feb; 58(2):137-145. PubMed ID: 32050284
[TBL] [Abstract][Full Text] [Related]
34. Endoscopic submucosal resection with an endoscopic variceal ligation device for the treatment of rectal neuroendocrine tumors.
Ebi M; Nakagawa S; Yamaguchi Y; Tamura Y; Izawa S; Hijikata Y; Shimura T; Funaki Y; Ogasawara N; Sasaki M; Joh T; Kasugai K
Int J Colorectal Dis; 2018 Dec; 33(12):1703-1708. PubMed ID: 30167779
[TBL] [Abstract][Full Text] [Related]
35. Endoscopic mucosal resection with a ligation device or endoscopic submucosal dissection for rectal carcinoid tumors: an analysis of 24 consecutive cases.
Niimi K; Goto O; Fujishiro M; Kodashima S; Ono S; Mochizuki S; Asada-Hirayama I; Konno-Shimizu M; Mikami-Matsuda R; Minatsuki C; Yamamichi N; Koike K
Dig Endosc; 2012 Nov; 24(6):443-7. PubMed ID: 23078437
[TBL] [Abstract][Full Text] [Related]
36. Comparison of conventional and modified endoscopic mucosal resection methods for the treatment of rectal neuroendocrine tumors.
Lee HS; Moon HS; Kwon IS; Park JH; Kim JS; Kang SH; Lee ES; Kim SH; Sung JK; Lee BS; Jeong HY
Surg Endosc; 2021 Nov; 35(11):6055-6065. PubMed ID: 33094828
[TBL] [Abstract][Full Text] [Related]
37. Endoscopic resection yields reliable outcomes for small rectal neuroendocrine tumors.
Jeon JH; Cheung DY; Lee SJ; Kim HJ; Kim HK; Cho HJ; Lee IK; Kim JI; Park SH; Kim JK
Dig Endosc; 2014 Jul; 26(4):556-63. PubMed ID: 24447261
[TBL] [Abstract][Full Text] [Related]
38. The outcomes of modified endoscopic mucosal resection and endoscopic submucosal dissection for the treatment of rectal neuroendocrine tumors and the value of endoscopic morphology classification in endoscopic resection.
Wang XY; Chai NL; Linghu EQ; Qiu ST; Li LS; Zou JL; Xiang JY; Li XX
BMC Gastroenterol; 2020 Jun; 20(1):200. PubMed ID: 32586282
[TBL] [Abstract][Full Text] [Related]
39. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.
Sugimoto S; Hotta K; Shimoda T; Imai K; Yamaguchi Y; Nakajima T; Oishi T; Mori K; Takizawa K; Kakushima N; Tanaka M; Kawata N; Matsubayashi H; Ono H
Surg Endosc; 2016 Oct; 30(10):4239-48. PubMed ID: 26718357
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of endoscopic mucosal resection versus endoscopic submucosal dissection for rectal neuroendocrine tumors ≤10mm: a systematic review and meta-analysis.
Zhou C; Zhang F; We Y
Ann Saudi Med; 2023; 43(3):179-195. PubMed ID: 37270677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
